Stock Analysis

Rainbow Children's Medicare (NSE:RAINBOW) Strong Profits May Be Masking Some Underlying Issues

NSEI:RAINBOW
Source: Shutterstock

The stock price didn't jump after Rainbow Children's Medicare Limited (NSE:RAINBOW) posted decent earnings last week. We think that investors might be worried about some concerning underlying factors.

Check out our latest analysis for Rainbow Children's Medicare

earnings-and-revenue-history
NSEI:RAINBOW Earnings and Revenue History May 27th 2024

Examining Cashflow Against Rainbow Children's Medicare's Earnings

Many investors haven't heard of the accrual ratio from cashflow, but it is actually a useful measure of how well a company's profit is backed up by free cash flow (FCF) during a given period. The accrual ratio subtracts the FCF from the profit for a given period, and divides the result by the average operating assets of the company over that time. The ratio shows us how much a company's profit exceeds its FCF.

As a result, a negative accrual ratio is a positive for the company, and a positive accrual ratio is a negative. That is not intended to imply we should worry about a positive accrual ratio, but it's worth noting where the accrual ratio is rather high. To quote a 2014 paper by Lewellen and Resutek, "firms with higher accruals tend to be less profitable in the future".

For the year to March 2024, Rainbow Children's Medicare had an accrual ratio of 0.31. Unfortunately, that means its free cash flow was a lot less than its statutory profit, which makes us doubt the utility of profit as a guide. Over the last year it actually had negative free cash flow of ₹322m, in contrast to the aforementioned profit of ₹2.17b. We saw that FCF was ₹1.9b a year ago though, so Rainbow Children's Medicare has at least been able to generate positive FCF in the past.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On Rainbow Children's Medicare's Profit Performance

Rainbow Children's Medicare didn't convert much of its profit to free cash flow in the last year, which some investors may consider rather suboptimal. Therefore, it seems possible to us that Rainbow Children's Medicare's true underlying earnings power is actually less than its statutory profit. But the good news is that its EPS growth over the last three years has been very impressive. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. So while earnings quality is important, it's equally important to consider the risks facing Rainbow Children's Medicare at this point in time. For instance, we've identified 2 warning signs for Rainbow Children's Medicare (1 can't be ignored) you should be familiar with.

This note has only looked at a single factor that sheds light on the nature of Rainbow Children's Medicare's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.

Valuation is complex, but we're helping make it simple.

Find out whether Rainbow Children's Medicare is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.